Hey Gang,
I wanted to give you a quick update on the MSOS cannabis rescheduling trade. As many of you know, I’m currently long on MSOS, and it’s a core position for me right now.
We are currently in the middle of the recreational rescheduling hearing, which is set to last until July 15th. Once that concludes, the ALJ will provide a recommendation, followed by a final rule from the DEA. While the hearing plays out, I’m expecting a few more weeks of consolidation—but the technicals are quietly improving. We are sitting safely above both the 50-day and 200-day simple moving averages.
More importantly, the structural landscape of this ETF has fundamentally changed. The liquidity crunch that plagued cannabis stocks for years is resolving. Trulieve and Glass House now represent roughly 35% of the ETF, and both are fully liquid, with Trulieve already up-listed to the NYSE.
The stage is being set for an explosive move into the end of the year.
Subscribe to Pristine Capital Premium today to unlock the full video breakdown, including:
The specific M&A catalysts brewing between Curaleaf and Glass House.
How the 52-week range metrics for TRLV and GLAS are setting up to trigger massive momentum scanners.
A complete historical analysis of our Excel seasonality model showing why July and August have historically been massive turnarounds for this sector.
